Entera Bio Ltd. (ENTX)
NASDAQ: ENTX
· Real-Time Price · USD
2.00
0.00 (0.00%)
At close: Aug 18, 2025, 3:59 PM
2.00
0.00%
After-hours: Aug 18, 2025, 07:40 PM EDT
0.00% (1D)
| Bid | 1.9 |
| Market Cap | 91.33M |
| Revenue (ttm) | 223K |
| Net Income (ttm) | -4.96M |
| EPS (ttm) | -0.26 |
| PE Ratio (ttm) | -7.69 |
| Forward PE | 7.83 |
| Analyst | Buy |
| Ask | 2.1 |
| Volume | 61,781 |
| Avg. Volume (20D) | 122,453 |
| Open | 1.99 |
| Previous Close | 2.00 |
| Day's Range | 1.98 - 2.03 |
| 52-Week Range | 1.50 - 2.79 |
| Beta | 1.52 |
About ENTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ENTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ENTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
+10.75%
Entera Bio shares are trading higher after the com...
Unlock content with
Pro Subscription
5 months ago
+3.72%
Entera Bio shares are trading higher after entering a collaboration agreement with OPKO Health to advance a GLP-1/Glucagon candidate.
